Lung Cancer Clinical Trials

Showing 1261-1280 of 3,692 trials

Study of High Efficient Killing Cell Therapy for Advanced NSCLC

NCT03193567

The purpose of this study to preliminarily evaluate the safety and efficacy of High Efficient Killing Cell Therapy for refractory and advanced non-small cell lung cancer

Non Small Cell Lung Cancer

Ruijin Hospital15 participantsStarted Sep 2017

Shanghai, China

RECRUITINGPhase 2

A Phase 2 Clinical Study of ABSK061 and ABSK043

NCT06632262

The purpose of this study is to evaluate the anti-tumor activity of ABSK061 + ABSK043 in terms of overall response rate (ORR) in in Patients with Metastatic/Unresectable Solid Tumors with FGFR2/3 Alterations

HER2-Gastric/Gastroesophageal Junction CancerUrothelial CarcinomaNon-Small Cell Lung Cancer+1 more

Abbisko Therapeutics Co, Ltd202 participantsStarted Nov 2024

Guiyang, Guizhou, China • Guiyang, Guizhou, China • Shijiazhuang, Heibei, China +18 more locations

Study of High Efficient Killing Cell Therapy for Advanced NSCLC

A Phase 2 Clinical Study of ABSK061 and ABSK043

Related Searches

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions

Perioperative Treatment Outcomes of Early NSCLC

A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN)

A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies

Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease

A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.

TEIPP Immunotherapy in Patients With NSCLC

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment

Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

Functional Lung Imaging With DECT and 4DCT

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit